US Patent 7803910 Soluble CD164 polypeptides
Patent 7803910 was granted and assigned to Merck Serono S.A. on September, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+172 characters)
Article
Patent abstract
The present invention relates to sCD164 variants and therapeutic uses thereof, in particular for treating or preventing inflammatory or autoimmune disorders.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Amanda Proudfoot0
Christine Power0
Gabriela Saborio0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07803910 Soluble CD164 polypeptides US Patent 7803910 Soluble CD164 polypeptides
Infobox
Patent Number
078039100
Patent Number
78039100
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
078039100
Date of Patent
September 28, 2010
0Patent Application Number
118143890
Date Filed
January 24, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07803910 Soluble CD164 polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07803910
Date of patent
September 28, 2010
Patent application number
11814389
Date Filed
January 24, 2006
Patent primary examiner
Find more entities like US Patent 7803910 Soluble CD164 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
